BMJ 29(372):n71 Crocker TF, Lam N, Jordo M, Brundle C, Prescott M, Forster A et al (2023) Risk-of-bias assessment using Cochranes revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review
Despite these limitations, our findings suggest that, in certain scenarios, RWD could supplement RCT data through EHR to electronic data capture (EHR2EDC) automation 30
THINKING ABOUT PEPTIDES
Growth happens when your body rests and recovers
Even with a nutrient-dense diet, poor nutrient assimilation due to low stomach acid can result in sub-clinical and overt deficiencies
7,8,17 Moreover, the dual GIP and GLP-1 receptor agonist tirzepatide has also recently been clinically approved for the same applications